Aducanumab (APP Abeta) - Research Grade Biosimilar
Product Specifications
Background
Aducanumab has been used in trials studying the treatment of Alzheimer's Disease.
Immunogen
Homo sapiens / APP Abeta [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
BART, BIIB-037
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682427-100 1x 100 µL
P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400912-500 1x 500 µL
NGFR (Nerve Growth Factor Receptor) (NTR/912), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470908-100 1x 100 µL
Tyrosinase (T311 + OCA1/812), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742497-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/2497R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details